All things STOCKS

Must. Resist. Buying. More. Rocket.

I haven’t checked the price, but Wells Fargo might be a better idea. They keep their mortgages so their bottom line will improve with higher rates.
 
Won't the bottom line be hurt when interest rates rise and people stop buying houses?

Better positioned than their competitors would be a better way to put it. But the volume may not fall as much as home prices will level off (or even (gasp) fall). Home buyers tend to be able to spend X dollars per month. So if rates rise, home prices will fall (or at least level off for a while).

Stock prices are already adjusting. But you’re right. The profits for the lenders could be affected by lower new loan volumes. However the holders of the loans, like Wells Fargo, will have the lower volume off set somewhat with the higher rates. They’ll also see less refinancing of their existing loan portfolios once rates stop free falling which could help profits (not replacing higher rate mortgages with lower rate mortgages). There are a lot of moving parts. Wells still rebuilding after their scandal is another huge variable.
 
Last edited:
WFC is actually above its 52-week high today. And it’s trading at a 32x multiple. AND the dividend is below 1%. I’m not touching it today. It is discounted off of the all time high, but has more than doubled off of the 52 week low. Doesn’t look like a slam dunk to me. But they aren’t a pure play mortgage company either.

Not sure yet on Rocket. It bounced off of that morning low very nicely.
 
Teledoc (TDOC) is now a $22B market cap instead of about $50B not long ago. I like their business model and that Buffett and (I think) Bezos were on board. They are the industry leader, but I suppose that one of the major insurers (or drug retailers) could be disruptive if they enter that space. It is bothersome that they’ve not been profitable, but that is okay if they are investing back into their business like Amazon did for a couple of decades.
 
  • Like
Reactions: TheColdVolTruth
I recognize only a few of these names. I wonder if some are Kathy Wood darlings.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Stocks That Hit 52-Week Lows On Monday

5/10/21, 10:41 AM
May 10, 2021 10:41 AM ET (BZ Newswire) -- News



Monday morning saw 78 companies set new 52-week lows.

Intriguing Points:

The largest company by market cap to set a new 52-week low was Rocket Companies (NYSE:RKT).

Skillful Craftsman (NASDAQ:EDTK) was the smallest company when considering market cap to set a new 52-week low.

Soligenix (NASDAQ:SNGX)'s stock traded down the lowest, falling 14.84% to reach a new 52-week low.

Stocks that set new 52-week lows during the first half-hour of trading on Monday are as follows:

Rocket Companies (NYSE:RKT) shares reached a new 52-week low of $17.23 on Monday morning, moving down 3.4%.
Lufax Holding (NYSE:LU) shares hit a yearly low of $10.52. The stock was down 4.35% on the session.
Teladoc Health (NYSE:TDOC) stock achieved a new 52-week low on Monday morning, hitting $142.88 and moving down 4.21%.
GoodRx Holdings (NASDAQ:GDRX) shares set a new yearly low of $33.33 this morning. The stock was down 3.02% on the session.
QuantumScape (NYSE:QS) shares were down 6.11% for the day, having made a 52-week low of $28.61.
iQIYI (NASDAQ:IQ) shares were down 3.57% for the day, having made a 52-week low of $13.03.
Beyond Meat (NASDAQ:BYND) shares set a new yearly low of $103.90 this morning. The stock was down 4.96% on the session.
Yatsen Holding (NYSE:YSG) stock achieved a new 52-week low on Monday morning, hitting $8.90 and moving down 5.0%.
Ncino (NASDAQ:NCNO) shares were down 3.04% for the day, having made a 52-week low of $54.33.
Ionis Pharmaceuticals (NASDAQ:IONS) stock achieved a new 52-week low on Monday morning, hitting $35.54 and moving down 1.26%.
Varonis Systems (NASDAQ:VRNS) stock dropped to a yearly low on Monday of $45.80. Shares traded down 2.58%.
Galapagos (NASDAQ:GLPG) stock hit a yearly low of $70.77. The stock was down 3.96% for the day.
Adaptive Biotechnologies (NASDAQ:ADPT) stock dropped to a yearly low on Monday of $32.77. Shares traded down 4.77%.
BigCommerce Holdings (NASDAQ:BIGC) stock broke to a new 52-week low of $45.90 on Monday. Shares of the company traded down 3.43%.
JFrog (NASDAQ:FROG) shares made a new 52-week low of $34.54 on Monday. The stock was down 0.08% for the day.
Haemonetics (NYSE:HAE) shares moved 0.0% (flat) on Monday to hit a new 52-week low of $60.19, drifting 0.0% (flat).
Fisker (NYSE:FSR) stock set a new 52-week low of $10.37 on Monday, moving down 6.81%.
Reata Pharmaceuticals (NASDAQ:RETA) shares moved down 1.52% on Monday to hit a new 52-week low of $83.10, drifting down 1.52%.
MorphoSys (NASDAQ:MOR) stock hit a yearly low of $20.45. The stock was down 4.47% for the day.
Vertex (NASDAQ:VERX) shares set a new 52-week low of $16.92. The stock traded down 1.09%.
Relay Therapeutics (NASDAQ:RLAY) shares moved down 5.49% on Monday to hit a new 52-week low of $27.43, drifting down 5.49%.
LendingTree (NASDAQ:TREE) shares were down 3.92% for the day, having made a 52-week low of $175.82.
Seer (NASDAQ:SEER) stock drifted down 7.54% on Monday morning to hit a new 52-week low of $34.55.
Vivint Smart Home (NYSE:VVNT) shares moved down 3.11% on Monday to hit a new 52-week low of $10.03, drifting down 3.11%.
Deciphera Pharmaceuticals (NASDAQ:DCPH) stock broke to a new 52-week low of $33.01 on Monday. Shares of the company traded down 3.26%.
Aurinia Pharmaceuticals (NASDAQ:AUPH) stock hit a new 52-week low of $9.90. The stock was up 0.1% on the session.
Paya Holdings (NASDAQ:pAYA) stock set a new 52-week low of $9.96 on Monday, moving down 0.99%.
Lordstown Motors (NASDAQ:RIDE) stock broke to a new 52-week low of $7.46 on Monday. Shares of the company traded down 3.88%.
Travere Therapeutics (NASDAQ:TVTX) stock hit a yearly low of $19.32. The stock was down 2.07% for the day.
17 Education & Technology (NASDAQ:YQ) shares moved down 6.7% on Monday to hit a new 52-week low of $5.07, drifting down 6.7%.
Kiniksa Pharmaceuticals (NASDAQ:KNSA) shares fell to $14.24 on Monday, setting a new 52-week low with a shift of down 1.03%.
BioXcel Therapeutics (NASDAQ:BTAI) stock drifted up 0.75% on Monday morning to hit a new 52-week low of $29.60.
Bright Scholar Education (NYSE:BEDU) shares were down 0.18% for the day, having made a 52-week low of $5.50.
Cara Therapeutics (NASDAQ:CARA) shares set a new yearly low of $12.12 this morning. The stock was down 2.23% on the session.
Ebang International Hldgs (NASDAQ:EBON) shares set a new 52-week low of $3.15. The stock traded down 5.22%.
Social Capital Hedosophia (NYSE:IPOD) stock achieved a new 52-week low on Monday morning, hitting $10.15 and moving down 0.88%.
BEST (NYSE:BEST) stock hit $1.13 on Monday morning, setting a new 52-week low for a change of down 5.31%.
Accelerate Diagnostics (NASDAQ:AXDX) shares were down 5.82% for the day, having made a 52-week low of $6.80.
Flexion Therapeutics (NASDAQ:FLXN) shares set a new 52-week low of $7.06. The stock traded down 1.91%.
Athersys (NASDAQ:ATHX) stock broke to a new 52-week low of $1.48 on Monday. Shares of the company traded down 3.25%.
Syros Pharmaceuticals (NASDAQ:SYRS) stock hit a yearly low of $4.88. The stock was down 0.96% for the day.
Fangdd Network Group (NASDAQ:DUO) stock dropped to a yearly low on Monday of $3.63. Shares traded down 5.18%.
HF Foods Group (NASDAQ:HFFG) stock set a new 52-week low of $5.51 on Monday, moving down 1.4%.
Redhill Biopharma (NASDAQ:RDHL) shares set a new yearly low of $6.00 this morning. The stock was down 3.04% on the session.
BlueCity Holdings (NASDAQ:BLCT) stock broke to a new 52-week low of $6.54 on Monday. Shares of the company traded down 5.74%.
Co-Diagnostics (NASDAQ:CODX) shares were down 3.71% for the day, having made a 52-week low of $7.69.
PaySign (NASDAQ:pAYS) shares hit a yearly low of $3.43. The stock was down 2.52% on the session.
OptiNose (NASDAQ:OPTN) stock achieved a new 52-week low on Monday morning, hitting $2.95 and moving down 2.9%.
Progenity (NASDAQ:pROG) shares set a new 52-week low of $2.48. The stock traded down 6.62%.
Voyager Therapeutics (NASDAQ:VYGR) stock hit a new 52-week low of $3.96. The stock was down 5.8% on the session.
Galera Therapeutics (NASDAQ:GRTX) stock set a new 52-week low of $5.87 on Monday, moving down 0.66%.
LogicBio Therapeutics (NASDAQ:LOGC) shares fell to $4.52 on Monday, setting a new 52-week low with a shift of down 3.31%.
Calithera Biosciences (NASDAQ:CALA) shares made a new 52-week low of $2.00 on Monday. The stock was down 3.11% for the day.
Fusion Fuel Green (NASDAQ:HTOO) stock drifted down 4.09% on Monday morning to hit a new 52-week low of $10.49.
Axcella Health (NASDAQ:AXLA) stock set a new 52-week low of $3.51 on Monday, moving down 4.09%.
Galecto (NASDAQ:GLTO) stock hit a yearly low of $5.20. The stock was down 2.97% for the day.
Agile Therapeutics (NASDAQ:AGRX) stock hit a yearly low of $1.42. The stock was down 3.36% for the day.
Concert Pharmaceuticals (NASDAQ:CNCE) stock set a new 52-week low of $3.76 on Monday, moving down 4.49%.
Aquestive Therapeutics (NASDAQ:AQST) stock broke to a new 52-week low of $3.27 on Monday. Shares of the company traded down 2.01%.
Evofem Biosciences (NASDAQ:EVFM) shares set a new yearly low of $1.16 this morning. The stock was down 3.69% on the session.
Otonomy (NASDAQ:OTIC) shares reached a new 52-week low of $2.09 on Monday morning, moving down 2.22%.
GlycoMimetics (NASDAQ:GLYC) stock hit a new 52-week low of $2.21. The stock was down 1.75% on the session.
Dyadic International (NASDAQ:DYAI) shares made a new 52-week low of $3.95 on Monday. The stock was down 5.05% for the day.
Protara Therapeutics (NASDAQ:TARA) shares made a new 52-week low of $9.27 on Monday. The stock was down 4.58% for the day.
Meten EdtechX Education (NASDAQ:METX) stock hit a yearly low of $1.40. The stock was down 4.64% for the day.
Q&K International Group (NASDAQ:QK) shares moved down 7.25% on Monday to hit a new 52-week low of $1.76, drifting down 7.25%.
Avalon Globocare (NASDAQ:AVCO) shares set a new 52-week low of $0.88. The stock traded down 3.67%.
Powerbridge Technologies (NASDAQ:pBTS) stock dropped to a yearly low on Monday of $1.35. Shares traded down 1.44%.
F-star Therapeutics (NASDAQ:FSTX) shares were down 9.4% for the day, having made a 52-week low of $6.40.
Kiromic BioPharma (NASDAQ:KRBP) shares set a new 52-week low of $7.02. The stock traded down 10.0%.
Windtree Therapeutics (NASDAQ:WINT) shares reached a new 52-week low of $1.84 on Monday morning, moving down 5.41%.
Pulmatrix (NASDAQ:pULM) shares hit a yearly low of $0.85. The stock was down 3.78% on the session.
Hancock Jaffe (NASDAQ:HJLI) stock hit $5.21 on Monday morning, setting a new 52-week low for a change of down 5.03%.
Soligenix (NASDAQ:SNGX) shares fell to $1.00 on Monday, setting a new 52-week low with a shift of down 14.84%.
Trxade Group (NASDAQ:MEDS) shares moved down 6.12% on Monday to hit a new 52-week low of $3.53, drifting down 6.12%.
Sonnet BioTherapeutics (NASDAQ:SONN) shares set a new yearly low of $1.52 this morning. The stock was down 3.4% on the session.
PainReform (NASDAQ:pRFX) shares hit a yearly low of $2.60. The stock was down 4.62% on the session.
Skillful Craftsman (NASDAQ:EDTK) stock hit a yearly low of $2.08. The stock was down 1.85% for the day.

As other companies hit new 52-week lows, Benzinga will keep traders updated. Stay with us for further analysis on these and other companies.

Copyright © 2021 Benzinga (BZ Newswire, Financial Market Data & API’s - Benzinga). Benzinga does not provide investmentadvice. All rights reserved. Write to editorial@benzinga.com with any questions about this content. Subscribe to Benzinga Pro (Benzinga Pro | Fast Stock Market News).
 
  • Like
Reactions: TheColdVolTruth
I dunno how many technicians we have in here, but TDOC looks completely busted on a long term chart (weekly bars) as well. ~180 was a very important long-term support level that it has sliced right through over the last few weeks. It wouldn't surprise me if that thing fell all the way back into the mid 80s (fall 2008 highs) or maybe even all the way back to the IPO price.

PTON is totally busted too, and similar looking weekly chart.
 
I dunno how many technicians we have in here, but TDOC looks completely busted on a long term chart (weekly bars) as well. ~180 was a very important long-term support level that it has sliced right through over the last few weeks. It wouldn't surprise me if that thing fell all the way back into the mid 80s (fall 2008 highs) or maybe even all the way back to the IPO price.

PTON is totally busted too, and similar looking weekly chart.

I understand Peleton crashing and burning making more sense than TDOC. IMO TDOC is a much more viable business and just got too rich during the pandemic. With exercise machines often evolving into clothes stands I just can’t see those subscriptions not falling off.
 
Won't the bottom line be hurt when interest rates rise and people stop buying houses?
I used to be a real estate developer. In the residential market a small/moderate rise in mortgage interest rates was welcomed. People would want to buy or build a house "before the interest rates go up again". I heard it often.
I got married in 1981, and the mortgage rates were 16-18%. We got a "wrap around mortgage" at 10.5%, and we were tickled pink. Sellers were having to do that to sell their home.
Interest rates have been near zero for an extended period. I see significant inflation, but post pandemic is something unseen in 100 years. I've been wrong many times, particularly about I interest rates.
But yes, mortgage demand comes and goes. That's banking.
 
Last edited:
I understand Peleton crashing and burning making more sense than TDOC. IMO TDOC is a much more viable business and just got too rich during the pandemic. With exercise machines often evolving into clothes stands I just can’t see those subscriptions not falling off.

Great days for puts imo with it rising for no fing reason.
 
I understand Peleton crashing and burning making more sense than TDOC. IMO TDOC is a much more viable business and just got too rich during the pandemic. With exercise machines often evolving into clothes stands I just can’t see those subscriptions not falling off.

Hope you are right, just got 200 shares at $141.48
 
120x FORWARD earnings.

They spent a fortune advertising their bikes a year or so ago. I think that it pulled in a lot of stock purchases. Around $25/share is a much more reasonable valuation assuming they are able to continue growing sales.

If You Own Peloton Stock, It's Time to Sell | The Motley Fool
At least they did have the sense to create multiple revenue streams (via the classes you pay a monthly fee for). It still doesn't come close to justifying anything close to that valuation, but the company might end up being a zero without it.

I never totally understood the ramp to begin with. Yes, I know with lockdowns gyms were closed, but in response to it how many people were going to buy a $2k+ exercise bike? That is a discretionary purchase if there ever was one, and I don't see home exercise equipment ever being able to make the leap from "nice to have" to "have to have" (like smartphones). It has all the makings of a gigantic fad and they'll have to diversify if they want to stick around long-term.
 
Hope you are right, just got 200 shares at $141.48

I’m thinking long term rather than a quick flip. But those mid-cap healthcare companies sure seem to get re-organized frequently. TDOC sure looks like the leader but the EDOC ETF would be a good way to get exposure with less risk.
 
At least they did have the sense to create multiple revenue streams (via the classes you pay a monthly fee for). It still doesn't come close to justifying anything close to that valuation, but the company might end up being a zero without it.

I never totally understood the ramp to begin with. Yes, I know with lockdowns gyms were closed, but in response to it how many people were going to buy a $2k+ exercise bike? That is a discretionary purchase if there ever was one, and I don't see home exercise equipment ever being able to make the leap from "nice to have" to "have to have" (like smartphones). It has all the makings of a gigantic fad and they'll have to diversify if they want to stick around long-term.

Netflix managed to evolve their business while FitBit and GoPro struggled. Management’s ability to improvise will be extremely important for PTON. As noted in the Motley Fool article linked above, they really screwed up on the treadmill recall. They burned up a lot of goodwill with that misstep. I wouldn’t short PTON (or really any stock) but I could see nibbling on long term puts.

Edit: I think that they were more lucky than good at the pandemic timing. They had promoted the heck out of the bikes well before COVID and stay-at-home fell into their lap. They built up a brand and then failed to step up quickly when their treadmills were killing and maiming children.
 
  • Like
Reactions: 05_never_again
Probably should have grabbed more shares of RKT at the opening dip. But the markets are giving up today’s gains going into the close. $17.23 may not be Rockets low for the week.
 

VN Store



Back
Top